Peptide questions · Thymosin Alpha-1

Thymosin Alpha-1 side effects: what studies and users report

Reviewed Evidence: EstablishedPublished by PepVault

The side effects most commonly reported for Thymosin Alpha-1 are injection site reaction, fatigue and mild flu-like symptoms; the library’s evidence on it includes controlled trials in people.

The library holds no separate safety note for Thymosin Alpha-1.

What is commonly reported with Thymosin Alpha-1

  • Injection site reaction
  • Fatigue
  • Mild flu-like symptoms

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other healing & recovery compounds the library lists it for
EffectAlso listed for (of 18)
Injection site reaction6: TB-500, GHK-Cu, AOD-9604, Thymosin Beta-4 and 2 more
Fatigue5: TB-500, Thymosin Beta-4, ARA-290, Abaloparatide and 1 more
Mild flu-like symptomsNone: listed for Thymosin Alpha-1 alone
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track Thymosin Alpha-1 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which Thymosin Alpha-1 side effects the healing & recovery group shares

Across the 19 healing & recovery compounds in the library, the effects listed most often are headache (7 of 19), injection site reaction (7 of 19), nausea (rare) (7 of 19) and fatigue (6 of 19). Thymosin Alpha-1 shares 2 of its 3 listed effects with at least one other healing & recovery compound; mild flu-like symptoms is listed for Thymosin Alpha-1 alone.

Where the Thymosin Alpha-1 reports come from

The library rates the evidence on Thymosin Alpha-1 as established: clinical trials or FDA-approved use exist.

Of the library’s 4 research notes on Thymosin Alpha-1, 4 rest on clinical data.

Our 6 study pages on Thymosin Alpha-1: 2 clinical trials, 2 randomized trials and 2 meta-analyses.

So Thymosin Alpha-1 has controlled trials in people to set its listed effects against.

What our Thymosin Alpha-1 study pages report on safety

Thymosin Alpha-1 combo: 30.0% pCR before gastric cancer surgery

Clinical trial, human, 2026: Side effects of any grade occurred in 93.3%, grade 3 or worse in 26.7%, and immune-related side effects in 23.3%, while blood tests showed shifts in immune cells such as more CD8+ T cells.

Thymosin alpha-1: 3 deaths vs 7 in dialysis COVID-19 pilot so far

Randomized trial, human, 2023: There were 12 serious adverse effects linked to COVID-19: 5 in the thymosin alpha-1 group and 7 in the control group. The antibody results and the main safety and efficacy endpoints were still to be analyzed once all patients finished.

Questions people ask

What are the side effects of Thymosin Alpha-1?

The side effects most commonly reported for Thymosin Alpha-1 are injection site reaction, fatigue and mild flu-like symptoms; the library’s evidence on it includes controlled trials in people.

Do Thymosin Alpha-1’s side effects come from human studies?

The library rates the evidence on Thymosin Alpha-1 as established, and the library’s evidence on it includes controlled trials in people.

Which Thymosin Alpha-1 side effects are its own?

Among the healing & recovery compounds, the library lists mild flu-like symptoms for Thymosin Alpha-1 alone.

More on Thymosin Alpha-1

Track it in the app

PepVault for iPhone

Track Thymosin Alpha-1 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo